Source link : https://www.newshealth.biz/health-news/concerns-prompt-fda-to-seek-more-info-on-weekly-insulin/
The US Food and Drug Administration (FDA) has issued a “complete response letter” to Novo Nordisk regarding its biologic license application for once-weekly basal insulin icodec for the treatment of people with diabetes, meaning that it requires more from the company before the product can be approved. The FDA ‘s requests related to both the […]
Author : News Health
Publish date : 2024-07-11 08:29:38
Copyright for syndicated content belongs to the linked Source.
inHealth